Allergy Therapeutics (AGY) — Defensive Interval Ratio

Latest as of June 2025: 107 days

Allergy Therapeutics (AGY) has a Defensive Interval Ratio of 107 days as of June 2025. Defensive assets of GBX7.97 Million (cash GBX-, short-term investments GBX-, receivables GBX7.97 Million) cover 107 days of daily cash needs of GBX74.50K/day. See Allergy Therapeutics current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

107 days
Days of operational coverage

Defensive Assets

GBX7.97 Million
Cash + ST Investments + Receivables

Daily Cash Need

GBX74.50K
Current Liabilities ÷ 365

Current Liabilities

GBX27.19 Million
GBX

Allergy Therapeutics Defensive Interval Ratio (2002–2025)

This chart shows how Allergy Therapeutics's Defensive Interval Ratio has evolved across 24 annual periods from 2002 to 2025. As of June 2025, the ratio stands at 107 days, meaning defensive assets of GBX7.97 Million can fund 107 days of operations without new revenue. See Allergy Therapeutics balance sheet quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Allergy Therapeutics (2002–2025)

The table below presents the year-by-year Defensive Interval Ratio for Allergy Therapeutics from 2002 to 2025, covering 24 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Allergy Therapeutics (AGY) market capitalisation.

Year DIR (days) Defensive Assets (GBX) Daily Cash Need Cash ST Investments Change (days)
2025 107 days GBX7.97 Million GBX74.50K/day GBX- GBX- ▼ -36 days
2024 143 days GBX8.02 Million GBX56.29K/day GBX- GBX200.00K ▲ +3 days
2023 139 days GBX7.09 Million GBX50.86K/day GBX- GBX- ▼ -72 days
2022 212 days GBX10.47 Million GBX49.46K/day GBX- GBX- ▲ +87 days
2021 125 days GBX6.22 Million GBX49.95K/day GBX- GBX- ▼ -37 days
2020 162 days GBX8.08 Million GBX49.94K/day GBX- GBX- ▼ -50 days
2019 212 days GBX9.78 Million GBX46.19K/day GBX- GBX- ▲ +47 days
2018 164 days GBX6.59 Million GBX40.08K/day GBX- GBX- ▼ -9 days
2017 174 days GBX6.67 Million GBX38.41K/day GBX- GBX404.00K ▲ +314 days
2016 -140 days GBX-4.81 Million GBX34.30K/day GBX- GBX-10.33 Million ▼ -338 days
2015 197 days GBX4.01 Million GBX20.33K/day GBX- GBX783.00K ▲ +11 days
2014 187 days GBX3.31 Million GBX17.74K/day GBX- GBX345.00K ▼ -73 days
2013 260 days GBX5.42 Million GBX20.88K/day GBX- GBX2.00K ▲ +60 days
2012 200 days GBX4.24 Million GBX21.22K/day GBX- GBX483.00K ▲ +12 days
2011 188 days GBX5.75 Million GBX30.54K/day GBX- GBX- ▲ +91 days
2010 97 days GBX2.66 Million GBX27.35K/day GBX- GBX- ▲ +59 days
2009 38 days GBX2.28 Million GBX59.65K/day GBX- GBX- ▼ -83 days
2008 122 days GBX2.70 Million GBX22.21K/day GBX- GBX3.00K ▲ +30 days
2007 91 days GBX2.71 Million GBX29.76K/day GBX- GBX63.00K ▼ -92 days
2006 183 days GBX2.48 Million GBX13.53K/day GBX- GBX- ▲ +16 days
2005 168 days GBX2.81 Million GBX16.77K/day GBX- GBX- ▼ -37 days
2004 205 days GBX1.84 Million GBX8.98K/day GBX- GBX- ▲ +35 days
2003 170 days GBX1.86 Million GBX10.95K/day GBX- GBX- ▲ +64 days
2002 107 days GBX1.34 Million GBX12.58K/day GBX- GBX- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)